TNF and rheumatoid arthritis: Therefore, the key hypothesis of the present study is that treatment with TNF inhibitors in patients with active RA not only reduces systemic inflammation but also significantly improves cognitive function over a 6-month follow-up period, especially in domains vulnerable to chronic inflammation.